US 11242333
Inhibitors of plasma kallikrein
granted A61PA61P1/00A61P1/18
Quick answer
US patent 11242333 (Inhibitors of plasma kallikrein) held by KalVista Pharmaceuticals Limited expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KalVista Pharmaceuticals Limited
- Grant date
- Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/00, A61P1/18, A61P11/00, A61P13/12